Analysts are often seen as industry meteorologists, as a key component of their job is to analyze market conditions and spot trends within their coverage areas. In med tech, these gurus pay particularly close attention to merger and acquisition (M&A) activity and several analysts recently predicted that M&A activity will continue, if not accelerate. Canaccord Genuity's Jason Mills even offered up his thoughts on which stocks might be at the top of some buyers' shopping lists. If his theory is correct, some of the smaller med-tech firms may be due for some sunny days in terms of exit opportunity. Read More
